Inventor · disambiguated record
Kenneth C. Cundy
Also filed as: CUNDY KENNETH · CUNDY KENNETH C
52 granted patents·43 pending applications·4,611 citations·filing 1991–2022
99Inventor score
Top patents by PatentIndex Score
95 records- 0199US6818787B2Prodrugs of GABA analogs, compositions and uses thereofXENOPORT INC·Filed 2002·Granted Nov 16, 2004·99 cites·14 claims
- 0299US5977089AAntiviral phosphonomethoxy nucleotide analogs having increased oral bioavailabilityGILEAD SCIENCES INC·Filed 1998·Granted Nov 2, 1999·252 cites·3 claims
- 0399US5145684ASurface modified drug nanoparticlesSTERLING DRUG INC·Filed 1991·Granted Sep 8, 1992·2.1k cites·20 claims
- 0498US6043230AAntiviral phosphonomethoxy nucleotide analogs having increased oral bioavailabilityGILEAD SCIENCES INC·Filed 1999·Granted Mar 28, 2000·191 cites·1 claims
- 0598US5922695AAntiviral phosphonomethyoxy nucleotide analogs having increased oral bioavarilabilityGILEAD SCIENCES INC·Filed 1997·Granted Jul 13, 1999·181 cites·31 claims
- 0698US5302401AMethod to reduce particle size growth during lyophilizationSTERLING WINTHROP INC·Filed 1992·Granted Apr 12, 1994·410 cites·4 claims
- 0796US7601706B2Bile-acid conjugates providing for sustained systemic concentration of drugsXENOPORT INC·Filed 2006·Granted Oct 13, 2009·17 cites·33 claims
- 0896US7534813B2Levodopa prodrugs, and compositions and uses thereofXENOPORT INC·Filed 2008·Granted May 19, 2009·33 cites·25 claims
- 0996US5552160ASurface modified NSAID nanoparticlesNANOSYSTEMS LLC·Filed 1995·Granted Sep 3, 1996·478 cites·13 claims
- 1095US7342131B2Levodopa prodrugs, and compositions and uses thereofXENOPORT INC·Filed 2005·Granted Mar 11, 2008·32 cites·45 claims
- 1195US7101912B2Carbidopa prodrugs and derivatives, and compositions and uses thereofXENOPORT INC·Filed 2003·Granted Sep 5, 2006·98 cites·63 claims
- 1295US6972341B2Prodrugs of GABA analogs, compositions and uses thereofXENOPORT INC·Filed 2003·Granted Dec 6, 2005·59 cites·14 claims
- 1395US6069249AAntiviral phosphonomethoxy nucleotide analogs having increased oral bioavailabilityGILEAD SCIENCES INC·Filed 1999·Granted May 30, 2000·67 cites·1 claims
- 1494US7671089B2Levodopa prodrugs, and compositions and uses thereofXENOPORT INC·Filed 2007·Granted Mar 2, 2010·24 cites·25 claims
- 1594US7413536B1Substrates and screening methods for transport proteinsXENOPORT INC·Filed 2000·Granted Aug 19, 2008·38 cites·8 claims
- 1694US7323585B2Levodopa prodrugs, and compositions and uses thereofXENOPORT INC·Filed 2005·Granted Jan 29, 2008·26 cites·38 claims
- 1794US7265096B2Gemcitabine prodrugs, pharmaceutical compositions and uses thereofXENOPORT INC·Filed 2003·Granted Sep 4, 2007·62 cites·83 claims
- 1893US7144877B2Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugsXENOPORT INC·Filed 2001·Granted Dec 5, 2006·37 cites·4 claims
- 1993US7049305B2Bile-acid conjugates providing for sustained systemic concentration of drugsXENOPORT INC·Filed 2005·Granted May 23, 2006·11 cites·8 claims
- 2093US6225460B1Nucleotide analogsGILEAD SCIENCES INC·Filed 1999·Granted May 1, 2001·132 cites·2 claims
- 2192US8952006B2Morpholinoalkyl fumarate compounds, pharmaceutical compositions, and methods of useXENOPORT INC·Filed 2013·Granted Feb 10, 2015·15 cites·29 claims
- 2292US7186855B2Prodrugs of GABA analogs, compositions and uses thereofXENOPORT INC·Filed 2002·Granted Mar 6, 2007·51 cites·4 claims
- 2391US7956212B2Levodopa prodrugs, and compositions and uses thereofXENOPORT INC·Filed 2009·Granted Jun 7, 2011·11 cites·10 claims
- 2491US6992076B2Bile-acid derived compounds for providing sustained systemic concentrations of drugs after oral administrationXENOPORT INC·Filed 2001·Granted Jan 31, 2006·21 cites·9 claims
- 2591USRE38333EAntiviral phosphonomethoxy nucleotide analogs having increased oral bioavailabilityGILEAD SCIENCES INC·Filed 2002·Granted Nov 25, 2003·18 cites·5 claims
- 2690US6833140B2Orally administered dosage forms of GABA analog prodrugs having reduced toxicityXENOPORT INC·Filed 2002·Granted Dec 21, 2004·34 cites·29 claims
- 2789US6984634B2Bile-acid conjugates for providing sustained systemic concentrations of drugsXENOPORT INC·Filed 2001·Granted Jan 10, 2006·18 cites·5 claims
- 2888US8163958B2Levodopa prodrugs, and compositions and uses thereofXIANG JIA-NING·Filed 2011·Granted Apr 24, 2012·9 cites·14 claims
- 2988US7803785B2Gemcitabine prodrugs, pharmaceutical compositions and uses thereofXENOPORT INC·Filed 2009·Granted Sep 28, 2010·13 cites·18 claims
- 3088US7183259B2Amino acid conjugates providing for sustained systemic concentrations of GABA analoguesXENOPORT·Filed 2003·Granted Feb 27, 2007·18 cites·4 claims
- 3187US6900192B2Bile-acid conjugates for providing sustained systemic concentrations of drugsXENOPORT INC·Filed 2001·Granted May 31, 2005·14 cites·13 claims
- 3286US7678782B2Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugsXENOPORT INC·Filed 2006·Granted Mar 16, 2010·3 cites·4 claims
- 3384US7790708B2Prodrugs of GABA analogs, compositions and uses thereofXENOPORT INC·Filed 2006·Granted Sep 7, 2010·6 cites·6 claims
- 3484US7608602B2Gemcitabine prodrugs, pharmaceutical compositions and uses thereofXENOPORT INC·Filed 2007·Granted Oct 27, 2009·6 cites·31 claims
- 3584US7598235B2Bile-acid conjugates for providing sustained systemic concentrations of drugsXENOPORT INC·Filed 2005·Granted Oct 6, 2009·3 cites·10 claims
- 3683US11111271B2Therapeutic peptidesCOHBAR INC·Filed 2017·Granted Sep 7, 2021·6 cites·33 claims
- 3782US11332497B2Therapeutic peptidesCOHBAR INC·Filed 2021·Granted May 17, 2022·1 cites·28 claims
- 3882US7420002B2Amino acid conjugates providing for sustained systemic concentrations of GABA analoguesXENOPORT·Filed 2002·Granted Sep 2, 2008·14 cites·11 claims
- 3979US8906412B2GABA analog prodrug sustained release oral dosage formsXENOPORT INC·Filed 2014·Granted Dec 9, 2014·3 cites·23 claims
- 4078US10945984B2Methods of administering monomethyl fumarate and prodrugs thereof having reduced side effectsARBOR PHARMACEUTICALS LLC·Filed 2013·Granted Mar 16, 2021·1 cites·12 claims
- 4175US8048917B2Prodrugs of GABA analogs, compositions and uses thereofXENOPORT INC·Filed 2005·Granted Nov 1, 2011·1 cites·30 claims
- 4275US7645797B2Amino acid conjugates providing for sustained systemic concentrations of GABA analoguesXENOPORT INC·Filed 2008·Granted Jan 12, 2010·1 cites·14 claims
- 4374US2020147019A1Gaba analog prodrug sustained release oral dosage formsARBOR PHARMACEUTICALS LLC·Filed 2019·Application pending·0 cites
- 4473US7439350B2Nucleotide analogsGILEAD SCIENCES INC·Filed 2004·Granted Oct 21, 2008·4 cites·2 claims
- 4571US7220875B2Amino acid derived prodrugs of propofol, compositions and uses thereofGALLOP MARK A·Filed 2004·Granted May 22, 2007·11 cites·48 claims
- 4670US8168623B2Prodrugs of GABA analogs, compositions and uses thereofGALLOP MARK A·Filed 2010·Granted May 1, 2012·1 cites·9 claims
- 4770US2020323804A1Gaba analog prodrug sustained release oral dosage formsARBOR PHARMACEUTICALS LLC·Filed 2020·Application pending·0 cites
- 4868US11753445B2Therapeutic peptidesCOHBAR INC·Filed 2022·Granted Sep 12, 2023·0 cites·31 claims
- 4967US8795725B2GABA analog prodrug sustained release oral dosage formsCUNDY KENNETH C·Filed 2005·Granted Aug 5, 2014·1 cites·19 claims
- 5067US2008255073A1Compounds for sustained release of orally delivered drugsXONOPORT INC·Filed 2008·Application pending·0 cites
Showing the top 50 of 95 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Kenneth C. Cundy files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →